Synopsis of recent research by authors named "Xing-Jie Hu"
- Xing-Jie Hu's research predominantly focuses on the development of innovative therapeutic strategies for cancer treatment, utilizing advanced materials such as peptide-based constructs and self-assembling systems to enhance drug delivery and efficacy.
- Recent findings include the creation of bispecific nanoblockers and peptide-ferriporphyrin conjugates that improve tumor-specific targeting and enable enhanced ferroptosis therapy, alongside novel PROTACs that address off-target effects.
- Hu's work also explores the programmable design of biomaterials with aggregation-induced emission properties for imaging and therapeutic applications, providing promising insights into overcoming challenges in tumor penetration and drug resistance.
